Chemours Outlines Strategy Targeting Over $1B Adj. EBITDA and AI Market Growth

The Chemours Company released a new investor presentation detailing its strategic plan, "Pathway to Thrive," which reaffirms key financial targets and highlights a focus on high-growth end markets, particularly AI infrastructure and data centers. The company is targeting over $1 billion in Adjusted EBITDA, a significant increase from the $742 million reported for the trailing twelve months ending June 30, 2026.

Key Details

• Financial Targets: The company is aiming to achieve Adjusted EBITDA of over $1 billion, reduce net leverage to below 3.0x (from 4.4x in Q2 2026), and increase Free Cash Flow conversion to over 40%.
• Segment Outlook: The Titanium Technologies (TT) segment is targeting a mid-cycle Adjusted EBITDA floor of $400 million. The Advanced Performance Materials (APM) segment now derives over 40% of its Performance Solutions sales from AI infrastructure and advanced electronics.
• Strategic Initiatives: The "Pathway to Thrive" plan includes a goal to realize over $250 million in cost reductions from 2024 to 2027 and is targeting a sales CAGR of over 5% for the same period.